Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

OncoPLEX yields promising results in animal models of GBM

Sep. 14, 2021

C-118P demonstrates antiproliferative activity in models of HCC

Sep. 14, 2021

Pre-existing chromosomal instability may predict response to paclitaxel

Sep. 14, 2021

Janssen Pharmaceutica presents Mcl-1 inhibitors

Sep. 13, 2021

Inflazome patents NLRP3 inflammasome inhibitors

Sep. 13, 2021

JMJD1C demethylase as novel target for AR-negative prostate cancer

Sep. 13, 2021

Jiangsu Simcere Pharmaceutical R&D patents DNA repair protein RAD51 homolog 1 inhibitors

Sep. 13, 2021

At WCLC, early steps towards success against SCLC

Sep. 10, 2021

Platinum(II)-NHC complex targeting vimentin inhibits tumor metastasis

Sep. 10, 2021

Flamingo and Ionis expand alliance to develop RNA-targeted therapies for oncology

Sep. 10, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.